Members of the Centers for Disease Control and Prevention’s independent vaccine advisory panel voiced frustration Monday with the Biden administration’s plan to begin doling out Covid-19 boosters next month, arguing the announcement got ahead of federal regulators and could exacerbate vaccine hesitancy.
The White House strategy, which it announced earlier this month, is contingent upon FDA deeming boosters safe and effective and CDC recommending their use. Still, some CDC committee members made clear they were irked that the announcement came before federal regulators and scientists formally endorsed booster doses.
“That kind of opened the door to a lot of confusion,” said Sandra Adamson Fryhofer of the
→ Continue reading at Politico